IOL CHEMICALS & PHARMACEUTICALS LTD.
BSE: 524164
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 619.45+6.7% | 580.39+2.3% | 567.53+2.9% | 551.69+4.5% | 527.78+0.9% | 523.30-0.5% | 525.75 |
| Other Income | 1.74-67.1% | 5.29-23.1% | 6.88-6.6% | 7.37+63.1% | 4.52+11.1% | 4.07-36.7% | 6.43 |
| Total Income | 621.19+6.1% | 585.68+2.0% | 574.41+2.7% | 559.06+5.0% | 532.30+0.9% | 527.37-0.9% | 532.18 |
| EXPENSES | |||||||
| Expenditure | 550.36+0.6% | 546.92+2.4% | 533.89+4.0% | 513.52+5.4% | 487.40-2.4% | 499.55-1.3% | 506.24 |
| Tax | 17.65+153.2% | 6.97-33.7% | 10.52-9.2% | 11.58-12.8% | 13.28+82.7% | 7.27+7.1% | 6.79 |
| PROFIT | |||||||
| PBT | 70.83+157.1% | 27.55-32.0% | 40.52-11.0% | 45.54+1.4% | 44.90+61.4% | 27.82+7.2% | 25.94 |
| Net Profit | 53.18+158.4% | 20.58-31.4% | 30.00-11.7% | 33.96+7.4% | 31.62+53.9% | 20.55+7.3% | 19.15 |
| KEY METRICS | |||||||
| OPM % | 14.94%+7.00pp | 7.94%-2.12pp | 10.06%-1.21pp | 11.27%-0.66pp | 11.93%+11.81pp | 0.12%+0.60pp | -0.48% |
| NPM % | 8.56%+5.05pp | 3.51%-1.71pp | 5.22%-0.85pp | 6.07%+0.13pp | 5.94%+2.04pp | 3.90%+0.30pp | 3.60% |
| EPS | 1.81+158.6% | 0.70-31.4% | 1.02-12.1% | 1.16+7.4% | 1.08-69.1% | 3.50+7.4% | 3.26 |
Corporate Events
Board MeetingIOLCP
202414Nov
Board Meeting
consider and approve the Un-Audited Financial Results of the…
BSE Filing ↗ Board MeetingIOLCP
202414May
Board Meeting
consider and approve the Audited Financial Results of the Co…
BSE Filing ↗ Board MeetingIOLCP
20246Feb
Board Meeting
Consideration and approval of Audited Financial Results for …
BSE Filing ↗ Board MeetingIOLCP
20238Nov
Board Meeting
Consider and approve Audited Financial Results for Quarter a…
BSE Filing ↗ Board MeetingIOLCP
20239Aug
Board Meeting
Consider and approve Audited Financial Results for the quart…
BSE Filing ↗